LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Net revenues: 393.3K
Today's EPS Names:
SICP, MNSB, CFFI, More
EPS Growth %: +42.9%
Financial Fact:
Net revenues: 393.3K
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spotify (SPOT) Misses Q3 EPS by 36c; misses on guidance
- Gentherm (THRM) Misses Q3 EPS by 32c ; Offers Guidance
- UBS Downgrades Carrefour SA (CA:FP) (CRRFY) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
